who-eortc classification for cutaneous lymphomas - Dermatology

More documents

Recommendations

Info

References 1. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer Surveillance Series: Non-Hodgkin’s Lymphoma Incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000; 92:1240-1251 2. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas. A Proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood. 1997; 90:354-371 3. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon 2001 4. Grange F, Hedelin G, Joly P, et al. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome. The French Study Group on Cutaneous Lymphomas. Blood. 1999; 93:3637-3642. 5. Fink-Puches R, Zenahlik P, Bäck B, Smolle J, Kerl H, Cerrone L. Primary cutaneous lymphomas: applicability of current classification schemes (EORTC, WHO) based on clinicopathologic features observed in a large group of patients. Blood. 2002; 99:800-805. 6. Norton AJ. Classification of Cutaneous Lymphoma: a critical appraisal of recent proposals. Am J Dermatopathol. 1999; 21:279-287 7. Sander CA, Flaig MJ, Jaffe ES. Cutaneous manifestations of lymphoma: a clinical guide based on the WHO classification. Clin Lymphoma. 2001;2:86-100. 8. Russell-Jones R. World Health Organization of hematopoietic and lymphoid tissues:implications for dermatology. J Am Acad Dermatol. 2003;48:93-102. 9. Willemze R, Meijer CJLM. EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer. Am J Dermatopathol. 1999;21:265-73. 38
10. Beljaards RC, Meijer CJLM, van der Putte SCJ, et al. Primary cutaneous T-cell lymphomas. Clinicopathologic features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. J Pathol. 1994;172:53-60. 11. Bekkenk MW, Vermeer MH, Jansen PM, et al. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Blood. 2003;102:2213-2219. 12. Gonzalez CL, Medeiros LJ, Braziiel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15:17-27. 13. Burg G, Dummer R, Wilhelm M, et al. A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med. 1991;325:1078-1081 14. Salhany KE, Macon WR, Choi JK, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol. 1998;22:881-893. 15. Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis-like T-cell lymphoma. Am J Dermatopathol. 2001;23:206-215. 16. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610-627. 17. Hoque SR, Child FJ, Whittaker SJ, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol. 2003;148:516-525. 18. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997; 89:4501-4513. 19. Natkunam Y, Smoller BR, Zehnder JL, Dorfman RF, Warnke RA. Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. Am J Surg Pathol. 1999;23:571-581. 39
Page 1 and 2: Blood First Edition Paper, prepubli
Page 3 and 4: Introduction A variety of T-and B-c
Page 5 and 6: Primary cutaneous follicle center c
Page 7 and 8: 1B). The presence of intraepidermal
Page 9 and 10: acneiform lesions, indurated plaque
Page 11 and 12: Clinical features This condition sh
Page 13 and 14: Extracorporeal photopheresis (ECP),
Page 15 and 16: Clinical features C-ALCL affects ma
Page 17 and 18: The large atypical cells in the LyP
Page 19 and 20: Treatment Patients have generally b
Page 21 and 22: into either of these provisional en
Page 23 and 24: Immunophenotype The tumor cells cha
Page 25 and 26: Clinical features Patients are comm
Page 27 and 28: Definition Primary cutaneous margin
Page 29 and 30: indurated plaques, which may preced
Page 31 and 32: that expression of bcl-2 protein by
Page 33 and 34: Clinically, they show similarities
Page 35 and 36: Table 1. WHO-EORTC classification o
Page 37: Table 3. Characteristic features of
Page 41 and 42: 30. Jones D, Vega F, Sarris A, Mede
Page 43 and 44: 51. Smoller BR, Santucci M, Wood GS
Page 45 and 46: 73. Burns MK, Chan LS, Cooper KD. W
Page 47 and 48: 94. Lundin J, Hagberg H, Repp R. et
Page 49 and 50: 112. El Shabrawi-Caelen L, Kerl H,
Page 51 and 52: 133. Torne R, Su WPD, Winkelmann RK
Page 53 and 54: 154. Aarts WM, Willemze R, Bende RJ
Page 55 and 56: 175. Perniciaro C, Winkelmann RK, D
Page 57 and 58: Figure 6. Primary cutaneous CD4-pos
Page 59 and 60: fig 3 59
Page 61 and 62: fig 6 fig 7 fig 8 61

who-eortc classification for cutaneous lymphomas - Dermatology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?